Savills and Knight Frank have been appointed as joint leasing agents to market Skylab at the Francis Crick Institute at King’s Cross, London.
The 12,000 sq ft fully fitted CL2 wet laboratory and write-up space is located on the top floor of the biomedical research institute.
Skylab is designed to accommodate cutting-edge life science research and development and is ideally suited to innovative biotechnology, AI-enabled drug discovery, therapeutics, diagnostics and platform technology companies.
Stephen Mayhew, chief business officer at the Francis Crick Institute, said: “Skylab is a rare chance to occupy premium lab space within the Francis Crick Institute. Existing commercial collaborations and partners associated with the Crick have included some of the world’s most innovative life sciences organisations, creating significant opportunities for knowledge exchange, talent attraction and strategic partnerships.”
Tom Mellows, head of Savills science, added: “Skylab is truly a one-of-a-kind space, with no comparable laboratory currently available currently anywhere else in the UK, given both the quality of its fit-out and the strength of its science ecosystem. We anticipate that whoever takes the space will not only be at the forefront of scientific discovery, but also a true pioneer and scientific collaborator looking to establish a flagship R&D presence in London.”
Nick Blevins, partner, head of science and innovation, at Knight Frank, said: “For ambitious life sciences businesses, the ability to combine best-in-class laboratory space with immediate access to world-leading scientific expertise is a powerful proposition. Skylab offers occupiers a rare opportunity to accelerate growth and innovation from day one, benefitting from the talent, collaboration and connectivity that have made King’s Cross a leading life sciences destination. We’re delighted to support the Crick in finding the right partner for this exceptional space.”


